Several preclinical studies showed favorable binding affinity and imaging of melanoma cell lines using Abs and Ab fragments targeting immune checkpoints, PD-1/PD-L1 (9, 119, 340–345) and CTLA-4 (346). The gene discussed is CTLA4; the disease is melanoma.